Taysha Gene Therapies (TSHA) Other Non Operating Income (2022 - 2025)

Taysha Gene Therapies has disclosed Other Non Operating Income across 4 years of filings, most recently posting $736000.0 for Q4 2025.

• Other Non Operating Income for Q4 2025 came in at $736000.0, up 2528.57% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (up 478.2% YoY), and the FY2025 annual result was $1.2 million, up 7593.75% from the prior year.
• Other Non Operating Income came in at $736000.0 for Q4 2025 at Taysha Gene Therapies, up from $292000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $34.7 million in Q4 2023 to a low of -$195000.0 in Q2 2024.
• The 4-year median for Other Non Operating Income is -$3000.0 (2022), against an average of $2.4 million.
• Across the five-year window, Other Non Operating Income surged 579133.33% in 2023 and tumbled 6600.0% in 2024, its largest moves.
• Taysha Gene Therapies' Other Non Operating Income stood at -$6000.0 in 2022, then soared by 579133.33% to $34.7 million in 2023, then tumbled by 99.92% to $28000.0 in 2024, then jumped by 2528.57% to $736000.0 in 2025.
• The last three Other Non Operating Income figures came in at $736000.0 (Q4 2025), $292000.0 (Q3 2025), and $273000.0 (Q2 2025), per Business Quant data.